Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Liabilities from Discontinued Operations (2014 - 2015)

Updated

Sinovac Biotech (SVA) recorded Liabilities from Discontinued Operations of $243,000 in Q4 2015, down 66.6% from $727,000 a year earlier.

Analysis

Sinovac Biotech (SVA) Liabilities from Discontinued Operations (2014 - 2015) Analysis & Trends

  • Across earlier years, Liabilities from Discontinued Operations came in at $727,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 243,000.00
Dec 31, 2014 727,000.00
API Access

Sinovac Biotech Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=SVA&period=max&api_key=YOUR_API_KEY